Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors

Rod Mateo*, Gagandeep Singh, Nicolas Jabbour, Suzanne Palmer, Yuri Genyk, Lynda Roman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

Background. The role of radiofrequency ablation (RFA) in the treatment of hepatic metastases from recurrent ovarian tumors is undefined. Case. Three patients with hepatic lesions from recurrent ovarian cancers underwent a combined partial hepatectomy with radiofrequency ablation (RFA) to achieve optimal tumor cytoreduction. Follow-up radiological studies as well as serial tumor markers are consistent with disease-free survival after 39, 13, and 9 months. Conclusion. These results demonstrate the feasibility and safety of RFA for metastatic ovarian lesions to the liver in patients previously deemed as poor or non-surgical candidates, and suggest the potential for improvement in survival over unresected patients or in patients resected with residual disease.

Original languageEnglish
Pages (from-to)266-270
Number of pages5
JournalGynecologic Oncology
Volume97
Issue number1
DOIs
StatePublished - Apr 2005
Externally publishedYes

Keywords

  • Cytoreduction
  • Hepatectomy
  • Ovarian cancer
  • Radiofrequency Ablation

Fingerprint

Dive into the research topics of 'Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors'. Together they form a unique fingerprint.

Cite this